Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Optimizing local therapy deemed crucial for improving outcome of breast ductal carcinoma in situ
February 2nd, 2006
Optimizing local therapy was deemed crucial for improving the outcome of patients with ductal carcinoma in situ (DCIS). "We reviewed our institution's experience treating DCIS of the breast to determine risk factors for ipsilateral breast tumor recurrence (IBTR) and cause-specific survival (CSS) after breast-conserving therapy (BCT) or mastectomy," scientists writing in the International Journal of Radiation Oncology Biology Physics reported. "Between 1981 and 1999, 410 cases of DCIS (405 patients) were treated at our institution; 367 were managed with breast-conserving surgery (54 with lumpectomy alone and 313 with adjuvant radiation therapy...
Source: Women's Health Weekly (2006-02-02)
|
